Trials / Completed
CompletedNCT05128422
Normobaric Hyperoxia Combined With Endovascular Treatment for Acute Ischemic Stroke
Normobaric Hyperoxia Combined With Endovascular Treatment for Acute Ischemic Stroke Patients Within 6-24 Hours of Symptom Onset
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 120 (actual)
- Sponsor
- Capital Medical University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the safety and efficiency of normobaric hyperoxia combined with endovascular treatment for acute ischemic stroke patients with stroke onset 6-24 hours.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Normobaric oxygen therapy | it is simple to administer via oxygen storage facemask at flow rates of 10 L/min for 4 hours.This therapy should begin in the emergency room as early as possible when patients meet the inclusion criteria and are randomized to the experimental group |
Timeline
- Start date
- 2021-10-27
- Primary completion
- 2023-10-15
- Completion
- 2023-10-15
- First posted
- 2021-11-22
- Last updated
- 2024-07-31
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05128422. Inclusion in this directory is not an endorsement.